Startups
Torigen Pharmaceuticals is leading the pack in veterinary oncology. Our cancer vaccine uses the animal's tumor cells to create a personalized immunotherapy.
Overview
Employees
1-10
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Oct 5, 2017 | MassChallenge Boston Names Top 26 Startups | BOSTON, October 5, 2017 MassChallenge, the most startup-friendly accelerator on the planet, today announced the top 26 startups from its four-month accelerator program in Boston from its 2017 cohort of 128 companies. Representing some of th... |
| May 23, 2017 | MassChallenge Boston Announces 2017 Cohort | BOSTON, MAY 23, 2017 - MassChallenge, the most startup-friendly accelerator on the planet, today announced the 128 early-stage startups that have been accepted into the 2017 MassChallenge Boston accelerator program. Selected by a community ... |
Reviews 0
FAQ about Torigen Pharmaceuticals
What has the press written about Torigen Pharmaceuticals?
Parsers VC has collected 3 articles mentioning Torigen Pharmaceuticals, among them “MassChallenge Boston Names Top 26 Startups” (Oct 5, 2017) and “MassChallenge Boston Announces 2017 Cohort” (May 23, 2017).
Is Torigen Pharmaceuticals still active?
Yes, Torigen Pharmaceuticals is active; its latest activity on Parsers VC dates from Nov 3, 2017.